Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 701,000 | 700,820 | 666,637 | 636,210 | 600,333 |
| Cost of Goods | 59,000 | 57,637 | 54,057 | 52,007 | 69,399 |
| Gross Profit | 642,000 | 643,183 | 612,580 | 584,203 | 530,934 |
| Operating Expenses | 476,000 | 546,477 | 458,069 | 403,128 | 427,626 |
| Operating Income | 166,000 | 97,343 | 154,568 | 181,082 | 103,707 |
| Interest Expense | 24,000 | 23,207 | 19,971 | 3,971 | 651 |
| Other Income | 1,000 | 368 | 4,762 | 181 | 3,889 |
| Pre-tax Income | 143,000 | 74,504 | 139,359 | 177,292 | 106,945 |
| Income Tax | 51,000 | 7,885 | 323,116 | 7,077 | 15,622 |
| Net Income Continuous | 92,000 | 66,619 | -183,757 | 170,215 | 91,323 |
| Net Income | $92,000 | $66,619 | $-183,757 | $170,215 | $91,323 |
| EPS Basic Total Ops | 0.41 | 0.19 | -0.81 | 0.84 | 0.46 |
| EPS Basic Continuous Ops | 0.41 | 0.19 | -0.81 | 0.84 | 0.46 |
| EPS Diluted Total Ops | 0.41 | 0.20 | -0.81 | 0.83 | 0.45 |
| EPS Diluted Continuous Ops | 0.41 | 0.20 | -0.81 | 0.83 | 0.45 |
| EBITDA(a) | $263,000 | $191,080 | $204,290 | $190,467 | $117,463 |